Skip to content
Catalyst

curcuminFinding

Curcumin decreases fasting blood glucose

lowersModerate evidenceFindingreplicated ×6

01 · The sentence it was drawn from

“The overall evidence showed a statistically significant reduction in FBG in the T2D group from curcumin compared to placebo MD = −11.48 mg/dL, 95%CI (−14.26, −8.70), p < 0.01.”
Quoted verbatim from Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.
This finding among the 120 findings on its endpoint

curcumin

Fasting blood glucose

lowers

Effect as reported

−11.48mean difference

CI −14.26 to −8.7

Who
adults with type 2 diabetes
Dose studied
not reported

Moderate evidencePMID 39683570 · 2024

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Nutrients

Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.

2024PMID 39683570doi 10.3390/nu16234177

A later check left this paper out of the papers counted for curcumin; the finding stays because it matches the quoted sentence.

What else it reported2 findings · 1 compound · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3R2ZEP1N1RHS108FQ19K1B7